Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Medical genetics

Diagnosing ABL: Understanding Your Lab Results

At a Glance

Abetalipoproteinemia is suspected when LDL cholesterol and apoB are extremely low, often below 15 mg/dL, with possible vitamin deficiencies or acanthocytes on a blood smear. Testing for two MTTP mutations can support confirmation, while other causes of very low cholesterol must be excluded.

Diagnosing abetalipoproteinemia (ABL) requires a combination of specialized blood tests and genetic analysis. Because ABL is so rare, your doctor will look for a very specific pattern in your lab results—one that shows your body is unable to effectively produce the “transport ships” (lipoproteins) needed to move fats and vitamins [1][2]. Your doctor will also rule out secondary causes of very low cholesterol, such as malnutrition, hyperthyroidism, or advanced liver disease.

The Core Lipid Markers: LDL and apoB

The most striking feature of ABL is extremely low levels of cholesterol and certain proteins in the blood. Two markers are especially important clinical clues:

  • LDL-C (Low-Density Lipoprotein Cholesterol): Often called “bad cholesterol,” this is usually very low or even undetectable in ABL. Diagnostic guidelines often look for levels below 15 mg/dL [1][2].
  • Apolipoprotein B (apoB): This is the structural protein needed to build fat-transporting containers. In ABL, apoB levels are typically below 15 mg/dL or completely absent [1][2].

While these numbers (below 15 mg/dL) are highly suggestive in the right clinical context, they are not absolute diagnostic cutoffs and can vary with age and laboratory methods [3].

Examining Your Blood Under a Microscope

One of the unique signs of ABL is found by looking at your blood cells under a microscope, a test called a peripheral blood smear.

In some cases (reported around 58% in a review), patients have acanthocytosis [4]. This means your red blood cells look “spiky” or “thorny” instead of smooth and round [5][6]. These spikes occur because the lack of fats in your blood changes the structure of the red blood cell’s outer “skin” (membrane) [6]. While it is a variable morphological clue rather than a strict requirement—and it does not inevitably cause anemia—finding them is a major clue for your medical team [4].

The Role of Genetic Testing

Genetic testing can help confirm a diagnosis of ABL. Your doctor will look for mutations in the MTTP gene [7].

To have ABL, you must have two mutations—one from each parent. This is called a biallelic mutation [1]. You might have the same mutation from both parents (homozygous) or two different mutations in the same gene (compound heterozygous) [7][8]. Confirming an MTTP mutation helps distinguish ABL from other conditions, like HoFHBL (caused by the APOB gene). However, a negative genetic panel doesn’t always definitively rule out ABL (as some complex variants can be missed), and a “variant of uncertain significance” requires careful interpretation by a genetic counselor [9][10].

Your Completeness Checklist

When reviewing your lab reports, ensure you and your doctor have discussed each of these key areas:

Test Category Specific Lab Why it Matters in ABL
Lipid Profile LDL-C, Total Cholesterol, Triglycerides To identify the severe drop in blood fats typical of ABL [1].
Protein Markers Apolipoprotein B (apoB) To confirm the body lacks the primary building block for fat transport [2].
Vitamin Levels Vitamins A, D, E, and K To measure deficiencies and guide your doses. Vitamin E results may need interpretation relative to total lipids [11][12].
Blood Structure Peripheral Blood Smear To check for “spiky” red blood cells (acanthocytosis) [4].
Clotting Ability PT / INR (Prothrombin Time) A functional test of clotting time. A prolonged time may reflect Vitamin K status, but liver disease and other factors can also affect it [11].
Liver Health ALT / AST (Transaminases) To monitor for liver stress or fat accumulation in the liver [4][12].
Genetic Test MTTP Gene Analysis To help provide a definitive diagnosis and distinguish ABL from other conditions [7].

If any of these tests are missing from your records, it is worth asking your care team if they should be ordered to complete your clinical picture. Monitoring these labs regularly is a standard part of staying healthy with ABL [1].

Common questions in this guide

Can very low LDL and apoB levels alone diagnose abetalipoproteinemia?
No. LDL-C and apoB values below about 15 mg/dL are strong clues, but they are not absolute cutoffs and can occur with other causes of very low cholesterol. Clinicians also consider vitamin levels, blood-smear findings, liver tests, and genetic results while ruling out conditions such as malnutrition, hyperthyroidism, advanced liver disease, or HoFHBL.
What are acanthocytes, and do they prove ABL?
Acanthocytes are red blood cells with an irregular, spiky appearance on a peripheral blood smear. They can support an abetalipoproteinemia diagnosis, but they are found only in some patients, so their absence does not rule out the condition.
What does MTTP genetic testing show in abetalipoproteinemia?
Abetalipoproteinemia is usually confirmed by finding mutations in both copies of the MTTP gene, with one inherited from each parent. The mutations may be identical or different. A negative panel may not completely exclude the condition, and a variant of uncertain significance needs review by a genetic counselor.
Which laboratory tests are typically part of an ABL evaluation?
Evaluation may include a lipid panel, apoB, vitamins A, D, E, and K, a peripheral blood smear, PT/INR, ALT/AST, and MTTP analysis. Together, these tests assess very low blood fats, vitamin deficiencies, red-cell changes, clotting status, liver health, and the inherited cause.
What can a high PT or INR mean in abetalipoproteinemia?
A prolonged PT or elevated INR may reflect low vitamin K, but liver disease and other factors can also affect clotting tests. Do not change vitamin K or other treatment on your own; ask your clinician how the result fits with your vitamin levels, liver tests, and any bleeding symptoms.

Get notified when new evidence is published on Abetalipoproteinemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (12)
  1. 1

    Current Diagnosis and Management of Abetalipoproteinemia.

    Takahashi M, Okazaki H, Ohashi K, et al.

    Journal of atherosclerosis and thrombosis 2021; (28(10)):1009-1019 doi:10.5551/jat.RV17056.

    PMID: 33994405
  2. 2

    A novel mutation, Ile344Asn, in microsomal triglyceride transfer protein abolishes binding to protein disulfide isomerase.

    Valmiki S, Bredefeld C, Hussain MM

    Journal of lipid research 2025; (66(1)):100725 doi:10.1016/j.jlr.2024.100725.

    PMID: 39672332
  3. 3

    Generation of hepatoma cell lines deficient in microsomal triglyceride transfer protein.

    Anaganti N, Chattopadhyay A, Poirier JT, Hussain MM

    Journal of lipid research 2022; (63(9)):100257 doi:10.1016/j.jlr.2022.100257.

    PMID: 35931202
  4. 4

    A novel p.Gly417Valfs*12 mutation in the MTTP gene causing abetalipoproteinemia: Presentation of the first patient in Mexico and analysis of the previously reported cases.

    Rodríguez Gutiérrez PG, González García JR, Castillo De León YA, et al.

    Journal of clinical laboratory analysis 2021; (35(3)):e23672 doi:10.1002/jcla.23672.

    PMID: 33258201
  5. 5

    Impaired Cytoskeletal and Membrane Biophysical Properties of Acanthocytes in Hypobetalipoproteinemia - A Case Study.

    Cloos AS, Daenen LGM, Maja M, et al.

    Frontiers in physiology 2021; (12()):638027 doi:10.3389/fphys.2021.638027.

    PMID: 33708142
  6. 6

    Forty year follow-up of three patients with complete absence of apolipoprotein B-containing lipoproteins.

    Le R, Zhao L, Hegele RA

    Journal of clinical lipidology 2022; (16(2)):155-159 doi:10.1016/j.jacl.2022.02.003.

    PMID: 35221233
  7. 7

    High carrier frequency for abetalipoproteinemia and evidence of a founder variant in a French-Canadian population.

    Guay SP, Paquette M, Girard L, et al.

    Journal of clinical lipidology 2024; (18(4)):e625-e630 doi:10.1016/j.jacl.2024.04.132.

    PMID: 38908974
  8. 8

    Normal serum ApoB48 and red cells vitamin E concentrations after supplementation in a novel compound heterozygous case of abetalipoproteinemia.

    Di Filippo M, Collardeau Frachon S, Janin A, et al.

    Atherosclerosis 2019; (284()):75-82 doi:10.1016/j.atherosclerosis.2019.02.016.

    PMID: 30875496
  9. 9

    Current Diagnosis and Management of Familial Hypobetalipoproteinemia 1.

    Wakabayashi T, Takahashi M, Okazaki H, et al.

    Journal of atherosclerosis and thrombosis 2024; (31(7)):1005-1023 doi:10.5551/jat.RV22018.

    PMID: 38710625
  10. 10

    Homozygous familial hypobetalipoproteinemia: A Turkish case carrying a missense mutation in apolipoprotein B.

    Yilmaz BS, Mungan NO, Di Leo E, et al.

    Clinica chimica acta; international journal of clinical chemistry 2016; (452()):185-90.

    PMID: 26612772
  11. 11

    An Unusual Presentation of Hemorrhagic Disease in an Infant: A Probable Case of Abetalipoproteinemia.

    Sivamurukan P, Boddu D, Pulimood A, Agarwal I

    Journal of pediatric hematology/oncology 2021; (43(3)):e429-e430 doi:10.1097/MPH.0000000000001831.

    PMID: 32433446
  12. 12

    A New Case of Abetalipoproteinemia Caused by Novel Compound Heterozygote Mutations in the MTTP Gene without Fat or Vitamin Malabsorption.

    Sasaki K, Tada H, Komatsu T, et al.

    Journal of atherosclerosis and thrombosis 2024; (31(11)):1634-1640 doi:10.5551/jat.64730.

    PMID: 38749717

This page explains laboratory and genetic testing used to evaluate abetalipoproteinemia for informational purposes only and does not constitute medical advice. Your doctor and genetic counselor should interpret your results in the context of your overall health.